MANKIND grows Q2 revenue and approves merger of two subsidiaries
According to TradingView, MANKIND reported Q2 revenue of ₹4,337.86 crore and profit of ₹711.48 crore, and its board approved two subsidiary amalgamations.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, MANKIND's consolidated revenue in the second quarter reached ₹4,337.86 crore, while profit attributable to equity holders came to ₹711.48 crore.
The board approved the amalgamation of two subsidiaries. The company may also invest up to EUR 45 million in the Netherlands, including a 70% stake in ACTx.
why it matters
The story concerns a single Indian pharmaceutical company, so its impact on the broader market is limited. Investors following MANKIND may weigh the effect of the subsidiary restructuring and the CAR-T investment.
tags
instruments
sources
- MANKIND: Q2 growth accompanied by subsidiary streamlining and a major CAR-T investment — TradingView, 26 October 2026 at 09:41 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗